Lufuno Grace Mavhandu-Ramarumo's research while affiliated with University of Venda and other places

... Several studies conducted in Africa showed that a large diversity of alpha and beta-CoVs was detected in different bat species [114][115][116][117][118][119][120][121]. In Kenya, detected bat CoVs were phylogenetically different from human and animal CoVs based on sequence analysis of ORFs of these viruses [122]. ...

... Although most patients in this study were virally suppressed throughout the three time periods, these rates fell short of the global target of 95% suppression [57]. Previous studies have demonstrated that it would be beneficial to conduct more research to improve access to essential HIV care medical services to reduce the burden of adverse outcomes from COVID-19 [39,46,47]. ...

... Discordance proportions and agreement between self-report and laboratory detection were in keeping with a similar study conducted in the Kwazulu-Natal province, however non-disclosure of ART status (2.9%) was notably lower in our cohort compared to this study (8.1%) [9]. Several other studies in sub-Saharan Africa comparing self-report and biomarkers of current or previous ART use showed higher proportions of ART non-disclosure, however these studies had smaller sample sizes and the study population was not restricted to pregnant women presenting for antenatal care [21][22][23][24]. While the study by Huerga et al. in Kwazulu Natal found younger individuals were at higher risk of discordance, our study found no demographic risk factors for discordance [9]. ...

... Human herpes virus type 8 (HHV-8) is the causative agent of Kaposi sarcoma. The seroprevalence of HHV8 in Africa ranged from 2% to 100% depending on the regions [29]. Kaposi sarcoma was presented by 16 (6.95%) ...